Co-careldopa (Carbidopa/levodopa) vs Botulinum toxin type A
National NHS prescribing compared (Prescription Cost Analysis)
Co-careldopa (Carbidopa/levodopa) was dispensed 4,937.9× as often as Botulinum toxin type A in May 2026 — 128,386 items versus 26 in England.
128,386items
Co-careldopa (Carbidopa/levodopa) · May 2026
NHSBSA Prescription Cost Analysis
26items
Botulinum toxin type A · May 2026
NHSBSA Prescription Cost Analysis
Figure 1. Co-careldopa (Carbidopa/levodopa) versus Botulinum toxin type A: national items dispensed by month
▬ Co-careldopa (Carbidopa/levodopa) · ╌ Botulinum toxin type A
Source: NHSBSA Prescription Cost Analysis, to May 2026
| Measure | Co-careldopa (Carbidopa/levodopa) | Botulinum toxin type A |
|---|---|---|
| Items, May 2026 | 128,386 | 26 |
| Items, last 12 months | 1,551,158 | 220 |
| Net ingredient cost, May 2026 | £1,174,503 | £4,749 |
See the full profile for Co-careldopa (Carbidopa/levodopa) or Botulinum toxin type A.